LENTIBLAST PREMIUM TRANSDUCTION REAGENT
Cat# LBPX500
Size : 500uL
Brand : OZ Biosciences
LentiBlast Premium Transduction Enhancer
LentiBlast Premium is a novel dir="ltr">LentiBlast Premium Transduction Enhancer benefits:
-
Increase lentivirus infection efficiency for hard-to-transduce cells: The right solution for Stem cells, Primary T cells
-
Save effort & money: Achieve same transduction results with a lower viral titer
-
Maximize Cell Viability: Non-toxic
Sizes:
-
500 transductions in a 24-well plate.
-
1500 transductions in a 24-well plate.
Storage: -20>Request a sample
Catalog number | Unit Size | excl tax | Quantity / Buy |
LBPX500 | 500 | | |
LBPX1500 | 1500 | |
LBPX500
500
LBPX1500
1500
NAME | MOLECULE VECTOR | PRODUCT | REFERENCE | |
1321N1 | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Ollivier M. eNeuro. 2021 Jan 28;8(1):ENEURO.0185-20.2020 | |
1321N1 | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Ollivier M. Thesis Université Montpellier 2018. | |
AML | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Liu X. J Clin Invest. 2024 May 7:e175619. | |
AML | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Ren JG. J Clin Invest. 2023 Jun 15;133(12):e165510. | |
AU-565 | Lentivirus | LentiBlast Premium Transduction Enhancer | Cortez LM. PLoS Genet. 2019 Dec 16;15(12):e1008545. | |
BJ5ta | Lentivirus | LentiBlast Premium Transduction Enhancer | Teku G. Gene Chrom & cancer 2023 doi.org/10.1002/gcc.23176 | |
Bone marrow derived macrophages -lentiblast-premium-transduction-enhancer.html">LentiBlast Premium Transduction Enhancer | Fonseca GJ. Nat Commun. 2019 Jan 24;10(1):414. | |||
Bone marrow cells | Lentivirus | LentiBlast Premium Transduction Enhancer | Tricoli L. bioRxiv 2024 doi.org/10.1101/2024.03.14.584404 | |
Bone Marrow derived macrophages | Lentivirus | LentiBlast Premium Transduction Enhancer | Shen Z. Elife. 2022 Jan 20:11:e70878. | |
Bone Marrow Progenitor | retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Verdys P. bioRxiv. doi: https://doi.org/10.1101/2023.07.27.550674 | |
BRCA cell lines | retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Brown AL. Thesis 2020 | |
BSM | Lentivirus | LentiBlast Premium Transduction Enhancer | Esteves P. Eur Respir J . 2021 Nov 25;58(5):2004252. | |
BT-474 | Lentivirus | LentiBlast Premium Transduction Enhancer | Coxon M. Thesis Dissertation 2024 | |
BT-474 | Lentivirus | LentiBlast Premium Transduction Enhancer | Dennis M. PloS Genet. 2024 May 28;20(5):e1011293. | |
CAL-1 | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Pellegrini LM. bioRxiv 2024 doi.org/10.1101/2024.04.25.591064 | |
Cardiomyocytes | Lentivirus | LentiBlast Premium Transduction Enhancer | Garry D. Patent 2020 20200224218 | |
Cardiomyocytes | Lentivirus | LentiBlast Premium Transduction Enhancer | Singh BN. Nat Commun. 2018 Oct 12;9(1):4237. | |
CD34+ | Lentivirus | LentiBlast Premium Transduction Enhancer | Blood Adv . 2021 Nov 29;bloodadvances.2021004205. | |
CD34+ | Lentivirus | LentiBlast Premium Transduction Enhancer | Rousset F. Mol Ther Nucleic Acids. 2019 Mar 1;14:351-363. | |
D660 | Lentivirus | LentiBlast Premium Transduction Enhancer | Sajadi MM. bioRxiv [Preprint]. 2024 Oct 17:2024.10.14.618178. | |
ER-Hoxb8 | Lentivirus | LentiBlast Premium Transduction Enhancer | Alishala M. Challeng Res J. 2024 doi.org/10.5070/CR36572 | |
Ex vivo: AGM | retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Ma L. Sci Adv. 2022 Mar 4;8(9):eabm3470. | |
HEK-293 | Lentivirus | LentiBlast Premium Transduction Enhancer | Brown AL. Sci Rep . 2021 Oct 25;11(1):21008. | |
Hematopoietic Stem Cells | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Baroncini L. Front Immunol. 2024 Nov 7:15:1439328. | |
Hematopoietic Stem Cells | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Burton OT. Immunity. 2024 Jun 11:S1074-7613(24)00277-2. | |
Hematopoietic Stem Cells | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Raymond BBA. bioRxiv 2024 doi.org/10.1101/2024.05.20.594848 | |
HepG2 | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Cook NL. BMC Endocr Disord.BMC Endocr Disord. 2019 Oct 29;19(1):115. | |
hiPSC | retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Ryan SK. Star Protocol 2020 Dec. doi.org/10.1016/j.xpro.2020.100190 | |
HMEC | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Nassour J. Nature . 2023 Feb;614(7949):767-773. | |
HMEC | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Nassour J. Nature. 2019 Jan 23. doi: 10.1038/s41586-019-0885-0. | |
HT1080 | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Arnoult N. Nature. 2017 (549) 548.doi:10.1038/nature24023 | |
IMR-90 | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Nassour J. Nature. 2019 Jan 23. doi: 10.1038/s41586-019-0885-0. | |
Jurkat | lentiVirus | LentiBlast Premium Transduction Enhancer | Saed B. Biophys J. 2024 Mar 26:S0006-3495(24)00209-1. | |
Jurkat | lentiVirus | LentiBlast Premium Transduction Enhancer | Maurel Ribes A. medRxiv doi: https://doi.org/10.1101/2021.09.06.21262027 | |
Keratinocytes | LentiVirus | LentiBlast Premium Transduction Enhancer | Pickett-Leonard M. 2022 Thesis Dissertation U Min. | |
Keratinocytes | LentiVirus | LentiBlast Premium Transduction Enhancer | Thompson E. Thesis 2021 | |
LNCap | LentiVirus | LentiBlast Premium Transduction Enhancer | Chakraborty G. Clin Cancer Res. 2019 Dec 3. pii: clincanres.1570.2019 | |
LSK / LKS | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Ren JG. J Clin Invest. 2023 Jun 15;133(12):e165510. | |
Lymphocytes | LentiVirus | LentiBlast Premium Transduction Enhancer | Masuda S. J Immunother. 2024 Feb 1. doi: 10.1097/CJI.0000000000000503 | |
MDA-MB-231 | lentiVirus | LentiBlast Premium Transduction Enhancer | Evans G. T. Thesis University of Oxford (2023) | |
MDA-MB-453 | Lentivirus | LentiBlast Premium Transduction Enhancer | Coxon M. Thesis Dissertation 2024 | |
MEF | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Choi YG. Sci Rep. 2024 Nov 19;14(1):28688. | |
MEF | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Gong W. Nat Cell Biol. 2022 May;24(5):672-684 | |
Mesenchymal Stem Cells | LentiVirus | LentiBlast Premium Transduction Enhancer | Hom WW. bioRxiv https://doi.org/10.1101/2024.01.29.577837 | |
MM1S | Lentivirus | LentiBlast Premium Transduction Enhancer | Coxon M. Thesis Dissertation 2024 | |
Myeloid progenitor | Retrovirus | LentiBlast Premium Transduction Enhancer | Verdys P. EMBO J. 2024 Jul 18. doi: 10.1038/s44318-024-00173-7. | |
PrEC | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Nassour J. Nature. 2019 Jan 23. doi: 10.1038/s41586-019-0885-0. | |
Raji | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Sharma AU. bioRxiv 2021 https://doi.org/10.1101/2021.09.07.459239 | |
RAW 264.7 | retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Abe Y. Mol Cell 2023 Sep 14;S1097-2765(23)00693-7. | |
RPE-1 | Lentivirus | LentiBlast Premium Transduction Enhancer | Coxon M. Thesis Dissertation 2024 | |
SH-SY5Y | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Sanchez-Iglesias S. Neuroscience. 2018 Nov 15. pii: S0306-4522(18)30728-0. | |
SH-SY5Y | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Araújo-Vilar D. Eur J Hum Genet. 2018 Jan 24. doi: 10.1038/s41431-017-0052-8. | |
SCLC -lentiblast-premium-transduction-enhancer.html">LentiBlast Premium Transduction Enhancer | Kong R. Am J Respir Crit Care Med . 2022 Jul 18. | |||
SCLC -lentiblast-premium-transduction-enhancer.html">LentiBlast Premium Transduction Enhancer | Patel AS. Sci Adv. 2021 Jan 29;7(5):eabc2578. | |||
T lymphocytes | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Su H. Methods Mol Biol . 2024:2807:287-298. | |
T lymphocytes | Lentivirus | LentiBlast Premium Transduction Enhancer | Epstein AL. Patent 2023 WO2020168298A2 | |
T lymphocytes | Lentivirus | LentiBlast Premium Transduction Enhancer | Sta Maria NS. Sci Rep. 2021 Jul 23;11(1):15077. | |
T lymphocytes | Lentivirus | LentiBlast Premium Transduction Enhancer | Zheng L. Clin Cancer Res. 2020 Apr 9. pii: clincanres.3417.2019 | |
T lymphocytes | Lentivirus | LentiBlast Premium Transduction Enhancer | Zheng L. Int J Mol Sci. 2017 Dec 20;18(12). pii: E2773. | |
T lymphocytes CD4+ | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Claireaux M. Nature Commun 2022 Jan 26;13(1):521. | |
T lymphocytes CD4+ | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Zheng L. Int J Mol Sci. 2017 Dec 20;18(12). pii: E2773. | |
T lymphocytes CD4+ | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Epstein AL. Patent 2016 | |
T lymphocytes CD4+ | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Benati D. J Clin Invest. 2016 Jun 1;126(6):2093-108. | |
THP-1 | Lentivirus | LentiBlast Premium Transduction Enhancer | Chirayath TW. Nat Commun. 2024 Sep 18;15(1):8179. | |
THP-1 | Lentivirus | LentiBlast Premium Transduction Enhancer | Rogers BM. J Exp Med. 2021 Aug 2;218(8):e20201601 | |
Trabecular Meshwork | Lentivirus | LentiBlast Premium Transduction Enhancer | Greatbatch CJ. Hum Mol Genet. 2024 Jan 25:ddae003 | |
U266B1 | Lentivirus | LentiBlast Premium Transduction Enhancer | Coxon M. Thesis Dissertation 2024 | |
WI-38 | Retrovirus/Lentivirus | LentiBlast Premium Transduction Enhancer | Nassour J. Nature. 2019 Jan 23. doi: 10.1038/s41586-019-0885-0. |